NCT06457789View on ClinicalTrials.gov

Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

July 31, 2028

Conditions
NSCLC
Interventions
DRUG

[18F]F-AraG PET imaging

Patients will receive a static whole-body PET scan following a \[18F\]F-AraG injection.

DRUG

[89Zr]Zr-Df-Crefmirlimab PET imaging

Patients will receive a static whole-body PET scan following a \[89Zr\]Zr-Df-Crefmirlimab injection.

Trial Locations (1)

1081 HV

RECRUITING

Amsterdam UMC, location VUmc, Amsterdam

All Listed Sponsors
collaborator

Foundation for the National Institutes of Health

OTHER

lead

Amsterdam UMC, location VUmc

OTHER